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Background:  Left Ventricular Assist Devices (LVADs) are used as an advanced therapy 
for advanced heart failure in order to sustain patients until a heart transplant is available 
(bridge to transplant, ‘BTT’) or until the end of life (destination therapy, 'DT'). Despite 
the differences in treatment trajectory, BTT and DT patients receive the same education. 
Currently, it is unknown how the two groups compare to living with the LVAD regarding 
the adjustment process.   
Aims: This study aimed to explore LVAD patient experience, describe how patients 
construct the impact of the LVAD on daily life and self-care, and compare the findings 
between BTT and DT patients. It is imperative to understand how BTT and DT LVAD 
recipients construct the patient experience in order to provide patient-centric education 
for each group and promote optimal adjustment. 
Methods:  The study used a general qualitative methodology with a purposeful sampling 
of 20 LVAD recipients who self-reported as either BTT or DT. Atlas.ti V8 was used to 
manage transcribed interview data. Data content was analyzed, redundancy achieved, 
relevant themes identified through content analysis, and exemplars noted.  
Findings:  Participants reported the overarching theme, Living with an LVAD is 
inconvenient, but life-sustaining. BTT and DT LVAD participants contrasted the LVAD 




health aspirations. Six components emerged as necessary to LVAD adjustment among 
both groups: (1) physical ability, (2) caregiver dependence, (3) self-care, (4) roles, (5) 
LVAD public perception, and (6) connection. LVAD participants described differences in 
health aspirations based on the self-reported LVAD indication. 
Conclusions:  BTT and DT LVAD patients experienced a similar adjustment to the 
device. Despite the inconveniences of living with the LVAD, participants reported being 
grateful for the extended life. If faced with having to live with the LVAD for the 
remainder of life, most participants reported that it would not bother them, or they would 
be able to adjust. Increased knowledge regarding BTT and DT patient experience is 
required to develop patient-centric education and resources to ensure optimal LVAD 
adjustment.  
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Summary of the Study 
The purpose of the summary of the research study is to provide an overview of 
the study and to guide the readers through each section of the dissertation.  The study 
proposal provides the specific aims, the background and the significance, the research 
design and methods, and information regarding the protection of research participants. 
The bibliography completes the dissertation proposal.   
Two manuscripts, a review of the literature focusing on the current knowledge of 
influencing factors on LVAD adaptation (Manuscript A), and the primary findings of the 
current research study (Manuscript B) are included. 
Manuscript A, Influencing Factors on Left Ventricular Assist Device Adaptation: 
A Systematic Review, identified a need to expand research among the LVAD population 
regarding all the influencing factors of adaptation. The review identified the patient 
centric influencing factors on LVAD adaptation and organized under the four categories 
(physiologic-physical, self-concept/group identity, interdependence, role function) 
identified by Roy’s Adaptative Model (RAM). Emotional factors that did not clearly 
relate to any of the four RAM categories were associated with the patient as a bio-
psycho-social being, an assumption of the RAM model. A comprehensive assessment and 
understanding of influencing factors from the patients’ perspective are necessary to 
provide holistic LVAD care.  
Manuscript B, Left Ventricular Assist Device Adjustment Impacted by Assigned 
Patient Trajectory: A Qualitative Exploratory Study, identified the overarching theme 
Living with an LVAD is inconvenient but life-sustaining.  The model, Living with the 




patient experience, (1) illness perception, (2) LVAD adjustment, and (3) health 
aspirations. Within the model, six components were identified that impacted LVAD 
adjustment and the holistic self. The six components include (1) physical ability, (2) 
caregiver dependence, (3) self-care, (4) roles, (5) LVAD public perception, and (6) 
connection. The LVAD recipient's perceived LVAD trajectory (BTT or DT) influenced 
the LVAD adaption process. The holistic person, as well as health aspirations, were most 
heavily influenced by the perceived treatment trajectories and differed based on 
perceived BTT treatment trajectory or perceived DT treatment trajectory. The LVAD 
recipients that reported they were BTT expressed future motivations for heart 
transplantation. Those that reported DT described future aspirations of LVAD device 
longevity (e.g., support on LVAD therapy for more than ten years). Implications for 
future research and patient education are included. 
The appendixes contain the internal review board approval letters, protocol 








Heart failure (HF) affects approximately 8 million people in the United States 
(US) and exceeds $53 billion in total annual medical costs (Heidenreich, et al., 2013).  
Individuals diagnosed with end stage HF have an estimated survival rate of 50% (Rogers, 
et al., 2014).  Currently the superior treatment option for end-stage HF is heart 
transplantation (Yusen, et al., 2013); however, due to the limited number of available 
organs, left ventricular assist devices (LVADs) have become a life sustaining and 
effective treatment option. Prior to LVAD implant, HF patients are assigned an implant 
indication that communicates the device treatment trajectory.    There are two primary 
indications for LVAD therapy: (1) increase survival until heart transplantation, “Bridge-
to-Transplant” (BTT) or (2) manage HF symptoms until end of life, “Destination 
Therapy” (DT) (Rogers, et al, 2014).   Most often DT patients do not meet heart 
transplant criteria due to age, increased body mass index (BMI), or compliance.  
Currently almost half of those in the US implanted with a device are listed as DT 
(Kirklin, et. al., 2014). 
Living with an LVAD creates unique challenges and complexities due to the 
internal and external equipment required to operate the device (Abshire, et al, 2016).  
Some patients describe adjusting to the device as a “new reality” (Dwyer & Casida, 
2016).  However, it is unknown if the implant indication, BTT or DT, impacts the LVAD 
patient adjustment.  BTT patients must adhere to LVAD pre-scribed medical therapy for 
a limited time until receiving a heart transplant.  On the contrary, DT patients must adjust 
to LVAD prescribed medical therapy and the external device components until end-of-




LVAD patients are living greater than 10 years on a device and have an unknown 
potential life expectancy. BTT and DT patients receive the same LVAD education and 
follow the same self-care recommendations, despite the extreme differences in end of 
treatment trajectories and the length of time they must be supported on the LVAD. To 
understand the LVAD patient experience, researchers have utilized quality of life 
surveys; however, scarce information is available concerning the experience of living 
with an LVAD (Modica, et. al., 2014). More specifically, it is unknown if the implant 
indication, BTT or DT, influences the patient experience and impact of the LVAD 
on adjustment and self-care.  
This study will use a focused, generic, qualitative design with group and 
individual interviews.  Group interviews will be divided by self-reported implant 
indication, BTT or DT.  This approach allows respondents to present personal 
perspectives as well as respond to the perspectives of others with the same treatment 
trajectory (Polit & Beck, 2012). The overall objective of the study is to explore the 
patient BTT and DT LVAD experience.  The study will achieve the following aims:  
Aim 1: Describe the BTT and DT LVAD patient experience. 
Aim 2: Describe how BTT and DT LVAD patients construct the impact of the 
LVAD on daily life and self-care. 
Aim 3: Compare the experience and impact of the LVAD on adjustment and self-
care between BTT and DT patients.   
The knowledge gained from this study is expected to have an impact on how we 




care.   The study will describe how LVAD patients construct living with a device and the 
adjustment process.   
Research Strategy 
Significance 
LVADs are mechanical pumps that assist HF patients by unloading the left 
ventricle.  Approximately 2,000 patients are implanted annually in the United States (US) 
(Kirklin, et al., 2014). Seventy-eight percent of LVAD recipients live for one year or 
greater and almost 50% survive four years or greater on LVAD support (Kirklin, et al., 
2014).  Due to the limited availability of hearts for transplant, BTT patients are waiting 
longer on LVAD support while on the transplant list.  The redesigned HeartMate II was 
first implanted in 2003 (Frazier, et al., 2004) and the HeartWare in 2006 
(Leibman, 2006).  LVAD patients are living greater than 10 years on a device and have 
an unknown potential life expectancy.  Both the BTT and DT population are increasing.  
Due to an increase in advanced HF patients that do not meet heart transplant criteria, it is 
estimated 2.5-4.2% of the 8 million patients suffering from HF in the United States could 
benefit from a LVAD (Kirklin, et al., 2014).  
LVAD therapy is unique as compared to traditional HF management or other 
medical therapies. The LVAD internal and external components contribute to the 
complexities of adjusting to this treatment modality. The internal pump is implanted in 
the left ventricle and attaches to the aorta to increase the cardiac output.  The internal 
pump is connected to external components through a set of wires that exits the abdomen 
known as the driveline.  The driveline connects to an electronic microprocessor, the 




AC power supply or a set of batteries always. The external LVAD components 
significantly impact the patients’ activities of daily life (ADLs). Patients are not allowed 
to participate in water activities that might place the device at risk for getting wet or 
submerged (e.g., swimming, tub bathing, boating).  LVAD implant centers and state laws 
very regarding VAD patient’s ability to operate motor vehicles.  Depending on the 
physical requirements of an occupation or the employer’s comfort level with an LVAD, a 
patient’s ability to return to work despite the physical recovery may vary.  Patient’s 
recount LVAD adjustment in distinct phases: “Pre-LVAD (the time from first discussions 
for the device to surgery”, “Implant Hospitalization”, “Early Home Adaptation” and 
“Late Home Adaptation” (Abshire, et al, 2016).  
Review of the literature identifies some of the complexities of living with an 
LVAD.  In the hospital, the LVAD patient learns to care for the LVAD and manage 
emergency alarms.  Patients learn skills in the hospital related to the care of the LVAD.  
Upon hospital discharge they must learn to incorporate these skills into the home 
environment and daily activities (Casida, et al., 2011; Overgaard, et al., 2012; Sandau, et 
al., 2014; Ottenberg, et al., 2014; Chapman et. al., 2007).  During the “Early Home 
Adaption” phase, patients work towards independence but are heavily dependent upon 
the assistance of a support person for LVAD dressing changes, transportation, bathing, 
among other self-care activities, which can be a source of frustration (Modica, et. al, 
2014; Shapiro, Levin, & Oz, 1996).  Often changes to the home environment, including 
electrical work, are required to optimally support the LVAD.  Psychological stressors 




driveline.  Additional stressors include weekly clinic visits, testing, and travel to and from 
appointments (Casida, et al., 2011; Ottenberg, et al., 2014).  
During the “Late Home Adaptation” phase, patients report a change in their sense 
of normalcy including the ability to incorporate the LVAD into daily activities such as 
cooking, sleeping, and hygiene (Casida, et. al., 2011; Overgaard, et. al., 2012; Hallas, et. 
al, 2009; Chapman, et. al., 2007).  In this phase patients describe mixed emotions ranging 
from fear of LVAD complications (Casida, et. al., 2011; Overgaard, et. al., 2012; and 
Chapman, et. at. 2007) to an increasing confidence in self-care.  Some patients report a 
psychological transition from anxiety to gratitude towards the pump (Casida, et al., 2011; 
Ottenberg, et al., 2014).  Many describe the importance of returning to normalcy 
(Overgaard, et al., 2012), but also describe the difficulty of returning to work and 
resuming previous roles (Casida, et. al., 2011; Overgaard, et. al., 2012; Sandau, et. al., 
2014; Marcuccilli, et. al., 2011; Chapman, et. at. 2007).  Personal and social aspects of 
life can be significantly impacted by the LVAD.  Intimacy often requires modifications to 
accommodate the LVAD external equipment (Dwyer & Casida, 2016; Casida et. al., 
2009; Casida et. al., 2011).   
LVAD self-care requirements are the same for BTT and DT patients.  The main 
differences in the two groups is the anticipated length of time on LVAD support and the 
hope for a heart transplant.  The length of time BTT and DT patients live with an LVAD 
can vary dramatically.  LVAD BTT patients generally live with the device for several 
months, greater than six months to a couple of years.  In contrast, DT patients can live 
with a single device for greater than 10 years and longer if supported by consecutive 




and the ability to return to water activities.  It is unknown if the length of time a patient 
must live with an LVAD impacts the adjustment process or if patients adjust to the device 
differently, adhere to medical therapy, or experience LVAD therapy differently based on 
implant indication. Current qualitative literature fails to identify similarities and 
differences in the BTT and DT LVAD patient experience and the impact on daily life and 
self-care between the two groups. 
 Significance of the Expected Research Contribution  
The information gained through the exploratory study will increase the 
understanding of the complexities of living with a LVAD for BTT and DT patients.  The 
study will also compare the similarities and differences in BTT and DT patient 
adjustment.  This will provide a foundation that will be used to explore the influencing 
factors that lead BTT to adjust to meet transplant criteria (e.g., quit smoking, lose weight, 
increase medical therapy compliance).  Future studies will also explore the patient 
experience of BTT patients transitioned to DT (e.g., increase in body mass index, 
noncompliance, increase in age).  This study is the beginning of a research trajectory that 
will be used as a guide to evaluate and improve LVAD patient experience, education, 
improve LVAD nursing care and provide LVAD recommendations specific to implant 
indication.   
Innovation 
 Limited information is known as to the differences and similarities between 
LVAD BTT and DT patient experiences and how each group adjusts.  The status quo for 
clinical practice is to use the same education approach for BTT and DT patients despite 




LVAD patient experience patient may be on LVAD support at a single LVAD center, 
utilized small sample sizes (n < 20), and have focused on one implant indication.  No 
studies have compared or contrasted the BTT and DT LVAD patient experience. The 
proposed research study is innovative because it will be a multisite qualitative study and 
will utilize group and individual interviews to compare patient experience among LVAD 
BTT and DT patients.   
Conceptual Framework 
Callista Roy’s Adaptation Theory (1970) is a grand theory that focuses on the 
individuals’ ability to adapt with the internal and external environment and will be used 
to guide this research study. Roy’s Adaptive Model (RAM) is comprised of four key 
components: person, health, environment, and nursing (Roy, 1970).  A person is defined 
as a bio-psycho-social being that is constant interaction with a changing environment.  
Innate and acquired mechanisms are used to adapt.  The model includes peoples as 
individuals or groups (i.e., families, organizations, and communities).   How the patient 
interacts with the LVAD in the environment as well as influencing factors impact 
adjustment and mechanisms of adaptation will also be assessed.  Adaptation is 
manifested in RAM by four interrelated modes of behavior: 1) physiological, 2) self-
concept, 3) role function, and 4) interdependence (McEwen & Willis, 2014).  
Physiological includes the physical and chemical process involved in the function and 
activities of living organisms.  Self-concept refers to the psychological and spiritual 
integrity, sense of unity, meaning, purposefulness of universe.  Role function relates self 
to others, specifically the roles on people in society filling their needs for social integrity.  




and development.  Currently no study has assessed how patients are impacted by an 
LVAD in the four modes of behavior.  RAM aids in assessing the LVAD patient 
experience from a broad and comprehensive perspective.    
Approach 
A basic qualitative design, with an interpretative approach will be used to explore and 
describe LVAD patients’ experience (Green & Thorogood, 2014).  The aims for this 
research study are: 
Aim 1: Explore the BTT and DT LVAD patient experience. 
Aim 2: Describe how BTT and DT LVAD patient’s construct the impact of the LVAD 
on daily life and self-care. 
Aim 3: Compare the experience and impact of the LVAD on daily life and self-care 
between BTT and DT patients.   
 It is the expectation that knowledge gained from this study will provide insight 
into how clinical providers prepare and support LVAD patients from pre-implantation 
through the continuum of their care.  The research will provide a better understanding of 
the patient experience and influence how LVAD patients can best be prepared for LVAD 
in a manner that supports the patient’s specific implant indication and promotes 
adjustment.  A better understanding of the differences in BTT and DT patient experience, 
including similarities and differences may allow for development of implant indication 





Methods for Aims 1 - 3 
 Research Design. A basic qualitative design, with an interpretative approach will 
be used to explore, describe, and compare LVAD patients’ experience (Green & 
Thorogood, 2014).   
Sample and Setting.  To accurately describe influencing factors of adjustment in 
both BTT and DT LVAD patients purposive sampling will be used.  The PI will attempt 
to obtain variation in demographics, such as ethnicity, education level, age, gender, type 
of LVAD, and length of time supported by LVAD, in both groups.  Extreme or deviant 
case sampling and typical case sampling will also be utilized (Green & Thorogood, 
2004).  The sampling methods will provide extreme and typical influencing factors 
affecting LVAD adaptation.  The variety of demographics will provide perspectives 
among the LVAD patients across the adaptation experience, thereby increasing the 
credibility of the findings (Kuzel, 1999).   
 Participants will be interviewed until redundancy is reached in thematic content 
and saturation achieved in the depth and breadth of the topics discussed (Green & 
Thorogood, 2004). Therefore, based on other qualitative studies with in-depth interviews, 
it is estimated that redundancy and saturation will occur between 20-30 participants 
(Korstjens & Moser, 2018). The setting will be two LVAD programs located in a large 
metropolitan area in Southeast Texas. The programs collectively implant LVAD in 
approximately 200 LVADs annually and manage routine care for 300-400 collectively.  
 Group interviews will consist of patients from Baylor St. Luke’s Medical Center 
(BSLMC) and Memorial Hermann (MH). Interviews will be conducted in quiet, 




Houston Cizik School of Nursing Center for Nursing Research to allow patients the 
opportunity to speak openly without a relationship to the institution. If interviews are 
unable to be conducted at UTH, alternative locations will be used (e.g. BSLMC and MH 
conference room). Patients from both BSLMC and MH will be clustered by device 
implant indication, BTT or DT, to allow patients, the opportunity to speak openly 
concerning their experience during group interviews. Interviews will be scheduled in a 
timely manner from the time of recruitment and convenient for interview participants. 
Participant Recruitment. Study flyers will be placed in LVAD patient areas 
(e.g. LVAD outpatient clinics, LVAD inpatient units, patient support group meetings 
etc.). Clinical providers (e.g. Physicians, APRNs, LVAD Coordinators) will be asked to 
assist in identifying patients that meet study inclusion criteria and identify patient implant 
indication. Clinical providers will be asked to provide potential study participants flyers 
and ask them to contact the researchers if the PI is not available to consent in person.  
Prescreening and informed consent will occur in person in the LVAD clinics or via 
telephone.  The information will be maintained in a screening log. To adequately 
represent both BTT and DT patients, the PI will attempt to recruit adequate numbers of 
both groups. Once redundancy and saturation is reached in either the BTT or DT group, 
recruitment will cease for the specific group and only patients with the non-saturated 
group will be recruited. Inclusion criteria includes adult (age > 18 years), English 
speaking, currently living with a HeartMate II, HeartMate 3, or HeartWare device, and 
greater than 1-month post LVAD implantation.   
Potential research participants that meet inclusion criteria will be asked to provide 




Participants will be assigned a study number and information will be maintained in a 
linking log.   
Instruments. The PI will serve as the research instrument in the proposed 
qualitative study (Lincoln and Guba, 1985) and use reflexivity to address bias. A 
reflective journal will be used for the PI to distinguish between the PI’s subjectivity and 
the observable phenomenon. Research study field notes to capture other dynamics along 
with analytic and reflective notes will also be collected.   
 Data Collection.  A basic qualitative design, with an interpretative approach is 
needed to identify the experiences of LVAD patients (Green & Thorogood, 2014).  
Participants will provide written consent prior to enrollment into the study and before 
group or individual interviews. After proving consent, patients will be asked to provide 
written contact information for follow up interviews. Self-report demographic data will 
be collected via survey (Appendix A). Data responses will be coded and blinded.   
  Participants will be asked to share their experiences in group or individual 
interviews. Semi-structured interviews will be used to address themes and topics of 
interest in an information or conversation-style dialogue with the LVAD patients. Semi-
structured interviews allow the principle investigator (PI) to uncover and explore themes 
that might be unexpected but prove to be important in understanding the LVAD patient’s 
experience and adjustment (Kvale & Brinkman, 2009). The interviewer will guide the 
participants to share perceptions of their adjustment to the LVAD through a series of 
open-ended questions (Appendix B). The semi-structured interview guide was developed 
based on prominent themes published and gaps identified in the current literature on 




Marcuccilli et al., 2011; Casida et al, 2011; Hallas et al, 2008; Chapman et al, 2007). The 
interview guide will be further reviewed for relevance of questions and credibility will be 
established by the PI and 2-3 LVAD coordinators, who experts in care of the LVAD 
patient through the continuum of care (Polit & Beck, 2017). Triangulation will occur by 
interviewing different types of individuals in group and individual interviews to obtain 
multiple perspectives (Polit & Beck, 2017). The individual interviews will be conducted 
to further explore rich cases that align with the study aim or confounding cases 
(Brinkmann & Kvale, 2015). Individual interviews will be selected either from the group 
interviews or from interested research participants not able to attend the group interviews.  
Interviews will be emergent in design and allow the questions to adapt to further explore 
issues that arise from patient comments. (Brinkman & Kvale, 2015). Interviews will be 
conducted in English by the study PI using a semi-structured interview guide with grand 
tour and mini tour questions.   
 The group interviews will consist of approximately 5 to 10 patients and emergent 
in design and allow the questions to adapt to further explore issues that arise from patient 
comments. Patients will be clustered by device implant indication, BTT or DT, to allow 
patients, the opportunity to speak openly concerning their experience. The same semi-
structured interview guide will be used for the BTT and DT interview groups to compare 
experiences of the two groups. The emergent design will allow the questions to adapt to 
further explore factors that are specific to each group. Field notes/observations will be 
taken by the PI during recruitment and interviews to document the inflections, tones, and 
nonverbal cues (Kvale & Brinkman, 2009). At the end of the interview dependability will 




complete and accurate (Polit & Beck, 2017). Patients will be informed that all names 
mentioned in the interview will and protected health information will be removed in the 
transcription of the interview. Patients may be asked to participate in individual 
interviews following group interviews.    
Data Management. Audio recordings will be downloaded onto a password-
protected server at UTH. Every audio file will be identified with a study identification 
number and uploaded onto the server. Audio files will be downloaded and shared with 
the transcriptionist via a secured shared site. Once the transcription is complete it will be 
loaded onto the server, with study identification, and the PI will be notified by email.  
The transcript will then be verified for accuracy and authenticity by the PI by listening to 
the audio recording and comparing it to the transcript (Polit & Beck, 2017). All 
references to names or places will be removed from the transcription. Audio recordings 
will be kept on the secure server until all study interview and transcripts are finished. At 
completion all recordings will be deleted, and the transcripts will be stored by study 
number on the password-protected server.  
Despite security measures and the use of study ID numbers, there could be a 
breakdown in protecting the identity of interview participants. If a breach in participant 
confidentiality were to occur, we will notify the participant and IRB as soon as the 
incident was discovered. We would create an action plan to prevent future breaches.  
Violations in the conduct of the study will also be reported to the IRB as soon as they are 
identified.   
  The PI will be appropriately trained for handling human subject-related data 




protected health information (PHI) data collected by the PI or disclosed by a participant 
will be de-identified. Study participants will be assigned a study identification (ID) 
number in lieu of a participant name.   
 Data Analysis. Data analysis of interviews, field and analytical notes will begin 
as soon data is collected. This will allow for evaluation of the effectiveness of the group 
interview techniques and questions for collecting information, and any necessary 
adjustments will be made early in the interview process. Data collected will be de-
identified. The PI will review and become familiar with the data collected from the first 
participants (group interviews, journals, field notes, and artifacts) (Miles, Huberman, & 
Saldana, 2014). Transcriptions will be imported into Atlas’s version 8 for Windows 
(Scientific Software Development GmbH, 2017) for data coding, analysis, and 
management leading to preliminary themes. Codes will be identified and developed 
iteratively from the data and a codebook will be developed (Saldana, 2009). Codes will 
be established and categorized for themes, constructs, models, etc. (related to the research 
questions) by the PI. Supporting quotes will be used to support the data (Miles, et. al, 
2014). Transcriptions will be analyzed recursively validating the emerging themes and 
patterns. Data will be compared and contrasted to ascertain similarities and differences 
between the BTT and DT participants. Lastly, peer debriefing will be done with 
dissertation committee members who are familiar with the research approach, to 
substantiate the themes, eliminate bias and make the finding resonate with the providers, 
thereby establishing trustworthiness (Saldana, 2009). In qualitative research, the PI will 
serve as the research instrument (Lincoln and Guba, 1985). Therefore, to further enhance 




keeping a journal with analytic notes, to avoid bias (Korstjens & Moser, 2018).  
Sampling will continue until good depth and repetition or “saturation” of themes is 
reached, and little new information emerges (Green & Thorogood, 2004). Analytical 
notes will be taken throughout data analysis.  
Potential Problems and Alternative Strategies. Despite adequate population 
size, recruitment of patients can potentially be a challenge. Therefore, a contingency plan 
is in place. The Heart Exchange, a LVAD and heart transplant support group, is well 
established and eager for programs that may assist in increasing the understanding of 
LVAD patient illness perspective. Therefore, if recruitment lags, there are plans in place 
to work with Heart Exchange Support Group to supplement recruitment. Faculty advisors 
have experience recruiting from patient and family support groups for qualitative 
research interviews. They will provide guidance and recommendations for recruitment, as 
needed.  
Because the PI works at BSLMC as an Advanced Practice Registered Nurse 
(APRN), she may have encountered some of the study participants in a clinician role.  
The PI will emphasize the research role and verbalize that no responses will impact 
clinical care provided. The PI will also attempt to minimize clinical contact with research 
participants. To maintain the PI role, group interviews will be conducted at UTH Center 
for Nursing Research if possible and patients from both MH and BSLMC will 
interviewed together. The PI will also attempt to recruit and include patients in whom 
there is limited or no previous clinical provider encounter. Additionally, the PI will 





Risks to Human Subjects and Ethics 
Prior to study initiation, the study protocol will be reviewed and approved by the 
UTHealth Committee for the Protection of Human Subjects (CPHS) and Baylor St. 
Luke’s Medical Center and Memorial Hermann Institutional Review Boards (IRB), and if 
deemed necessary, additional safeguards and monitoring will be added to the protocol.  
All research team members will receive and maintain the UTHealth Protection of Human 
Subjects training.   
 The potential risks involve discomforts related to discussing symptoms of end 
stage HF and either waiting for or ineligible for heart transplantation. Therefore, patients 
will be clustered by implant indication to create a more homologous group and increase 
the patients’ ability to share openly.  Additional potential risks associated with the study 
are loss of confidentiality.  Mechanisms are in place to minimize these risks.  All 
participating patients prior to the study onset will provide verbal informed consent 
approved by the UTHealth CPHS and IRB.  All patients will be given the opportunity to 
refuse participation in the study and will be told that non-participation will not affect 
services (e.g., MH LVAD/HF Clinic service, BLSMC LVAD/HF Clinic, United Network 
for Organ Sharing (UNOS), etc.).  To protect the confidentiality of the patients, all hard-
copy records will be filed in locked cabinets and electronic records password protected 
computer systems within locked offices within the UTHealth School of Nursing for use 
by authorized personnel only.  Hardcopy files (e.g., informed consents) will be saved 
securely during and after study completion until proper data destroying, if applicable 
following established UTHealth guidelines.  All necessary firewall and password 




will be shared with their informal caregiver and vice versa.  All patients’ records will be 
given a unique study identification number. No PHI will be used in reports.  No PHI will 
be kept on the secured computer where the study data is collected, managed or stored.   
 The PI will regularly consult with faculty advisors concerning confidentiality, 
data management and participant safety concerns.  Although it is anticipated that any 
negative thoughts or feelings will be manageable, appropriate measures will be taken to 
ensure the safety of the patients.  During the interviews if any of the patients become 
upset, they will be offered the option of withdrawing from the study without penalty or 
continuing at another time.  Patients will also be informed that they may choose not to 
answer any item(s).  In the event of any emotional distress, the PI and research staff will 
remain with the participant until the participant is no longer distressed or appropriate 
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Left Ventricular Assist Devices (LVADs) are mechanical pumps that assist 
advanced heart failure (AHF) patients by unloading the left ventricle and increasing 
cardiovascular circulation throughout the body. LVADs are the most widely used heart 
pump. There are two primary indications for LVAD therapy (e.g., bridge to transplant 
[BTT] and destination therapy [DT]). Both groups experience similar self-care 
requirements with the LVAD; however, the length of time supported on therapy for the 
two groups can vary greatly. At present, LVAD training and patient education are the 
same for both groups. To date, no studies have explored if patients adjust differently to 
the devices based on the implant indication. This information is essential to optimize 
patient experience and facilitate the LVAD patient’s adjustment to living with the 
therapy. Furthermore, LVAD adjustment has the potential to impact patient morbidity 
and mortality directly. 
LVADs are increasing as a therapy option for patients experiencing AHF. Over 
30,000 AHF patients were implanted globally in the past decade, and approximately 
2,000 patients are implanted with LVADs annually in the United States (U.S.) (K.L et al., 
2014). LVADs have demonstrated the ability to improve the quality of life and improve 
the mortality of AHF patients (Grady et al., 2014). The internal pump is implanted in the 
left ventricle and attaches to the aorta to increase the cardiac output. It connects to 
external components through a set of wires that exit the abdomen known as the driveline, 
which connects to an electronic microprocessor, the "controller," that operates the device. 
LVAD patients must always rely on external batteries or an AC power source to support 




Unlike other medical therapies with only internal components, LVAD patients 
have external equipment that the LVAD recipient and caregiver must learn to manage. 
LVAD patients cannot participate in activities that place the patient, driveline, and 
equipment at risk of getting wet or submerged in water. Due to these factors, the external 
LVAD components significantly impact the patients’ activities of daily living  (e.g., 
driving, swimming, tub bathing, or boating) and create a complex adjustment process. In 
addition to modifications necessary for ADLs, LVAD recipients must learn to change 
power sources, ensure access to an adequate power supply, perform regular sterile 
dressing changes to the driveline exit site, and respond to hazardous and critical LVAD 
alarms. 
Review of Qualitative Literature  
 To date, a limited number of qualitative studies have explored LVAD adaptation 
in patients living with a second or third generation continuous-flow LVAD. One study 
described the importance of LVAD patients being able to be independent in most ADLs 
living or activities that the LVAD recipient valued as important (Sandau et al., 2014). 
Multiple studies have reported participants’ gratitude for the LVAD. The gratitude was 
reported and expressed as the opportunity to 'feel alive again' or gaining a 'new lease on 
life', previously thought as impossible while living with AHF (Casida et al., 2011; 
Ottenberg et al., 2014; Overgaard et al., 2012). In contrast, some participants verbalized 
ambivalence towards the LVAD (Overgaard et al., 2012).  
Multiple studies reported the importance of LVAD recipients to regain a sense of 
normalcy (Casida et al., 2011; Sandau et al., 2014), which included being able to 




valued as extremely important in the adjustment process and minimized the sense of 
isolation and loneliness of living with the device (Modica et al., 2015; Ottenberg et al., 
2014). Vocational adjustments were important component of regaining normalcy. A 
Danish study identified younger LVAD recipients struggled more returning to 
employment than older recipients that may be more established in careers before the 
LVAD or retired (Overgaard et al., 2012). This study emphasized the importance of 
evaluating physical, psychological, social, and vocational adjustments of LVAD 
recipients based on developmental age (Overgaard et al., 2012).  
A study focused on DT LVAD recipients, emphasized preparedness planning 
before receiving the LVAD, optimizing support networks, systemic limitations of living 
with an emerging therapy (Ottenberg et al., 2014). In another study exploring BT LVAD 
recipients' experience, the emphasis was placed on a sense of freedom from AHF only to 
be dependent on the LVAD. Waiting on a heart transplant only magnified the desire for 
freedom (Modica et al., 2015). During the waiting period for a heart transplant, the 
concept of time also took on a new meaning (Ottenberg et al., 2014). LVAD recipients 
viewed the LVAD as a prosthetic organ or 'experimental,' and the reliability of the device 
questioned over time (Modica et al., 2015). A study conducted in the United Kingdom, 
reported the LVAD created a liminal identity, served as a temporal disruption to one’s 
life while waiting on a transplant, and the devices itself served as a liminal object 
supporting the recipient only until a new heart was available (Standing et al., 2017).  
Complexities of Living with an LVAD  
The external equipment presents unique challenges and complexities of living 




regarding LVAD maintenance (e.g., e.g., system maintenance, securing adequate power, 
driveline immobilization, and driveline dressing changes) (Kato et al., 2014) and 
managing emergency alarms. Once patients return home, they must learn to incorporate 
these skills into their home environment and  activities of daily living (e.g., hygiene, 
medication adherence, physical activity, nutrition, sleep, and rest) (Kato et al., 2014).  
One study identified that adjustment and incorporating LVAD self-care to the 
LVAD is a process that occurs in two phases: (1) early home adaptation and (2) late 
home adaptation (Casida et al., 2011). During the early home adaptation phase, patients 
often notice an increase in energy and physical ability. Despite this increase, LVAD 
patients remain heavily dependent upon a caregiver for assistance performing activities 
related to hygiene, medication adherence, and transportation, among other self-care 
activities, which can be a source of frustration (Casida et al., 2011). Often changes to the 
home environment (e.g., electrical work to support the device, home generators) are 
required to support the LVAD optimally.  
Additional studies identified the following inconveniences during LVAD 
adjustment: frequent travel for clinical appointments and laboratory services, 
psychological stressors (e.g., alterations in body image and surgical scares) (Chapman et 
al., 2007; Linda Marcuccilli et al., 2013), and modifying equipment during physical 
activity (e.g., exercise and sexual intimacy) (Alonso et al., 2018; Hallas et al., 2009; 
Marcuccilli et al., 2011). 
In other studies, patients discussed a change in their sense of normalcy including 
the ability to improve in the management of the LVAD and incorporate daily activities 




et al., 2009; Overgaard et al., 2012). In the early home adaptation phase, the LVAD 
patient often describes mixed emotions ranging from fear of LVAD complications to 
increasing confidence in self-care (Casida et al., 2011; Chapman et al., 2007; Overgaard 
et al., 2012). During late adaptation, LVAD patients also described difficulties returning 
to work and resuming previous roles.  Patients discussed the difficulty of returning to 
work and resuming previous roles (Casida et al., 2011; Chapman et al., 2007; L. 
Marcuccilli & Casida, 2011; Overgaard et al., 2012; Sandau et al., 2014). Most 
importantly, LVAD patients described the importance of returning to normalcy, including 
the desire to appear normal in public (Casida et al., 2011; Ottenberg et al., 2014; Sandau 
et al., 2014) 
LVAD Implant Indication 
The two most commonly used device implant strategies include bridge to 
transplant (BTT) and destination therapy (DT). BTT is an implant indication used for 
patients actively listed for heart transplantation, utilizing an LVAD to prevent death or 
progressive end-organ dysfunction while awaiting transplant (Shudo et al., 2017). DT is 
an implant indication for patients who are not eligible for heart transplantation due to 
relative or absolute contraindication (e.g., body mass index, age, substance abuse, or 
malignancies) that will be supported by the LVAD for the remainder of life (Shudo et al., 
2017). Despite the clinical implant indication at the time of LVAD surgery based on the 
recipients' ability to meet heart transplant criteria, implant indication can also evolve as 
the patient's conditions regarding transplant eligibility change over time (e.g., abstinence 




The self-care requirements are the same for BTT and DT patients. The main 
differences in the two groups are the anticipated length of time on LVAD support and the 
anticipation of a heart transplant. The length of time BTT and DT patients live with an 
LVAD can vary dramatically. LVAD BTT patients may receive a heart transplant as 
early as six months after LVAD implant or may wait a couple of years supported on the 
device. Twenty to thirty percent of BTT patients receive a heart transplant by one year 
after device implantation (Kirklin et al., 2015). LVAD therapy is often most beneficial to 
patients that have extended time on the transplant waiting list (e.g., ABT blood type, 
large body habitus, or the presence of anti-HLA antibodies) (Shudo et al., 2017).   
Due to the advancements in technology and improvements in patient care, the use 
of LVADs for patients has increased dramatically for patients not meeting transplant 
eligibility. In the 2006-2007 INTERMACS registry, 14.7% of patients received an LVAD 
as DT, which quickly increased to 46% by 2011-2014, making DT the prevailing strategy 
among all LVAD implantations (Kirklin et al., 2014, 2015). Patients can live as DT with 
a single device for greater than ten years and longer if supported by consecutive devices. 
DT LVADs have the potential to not only reduce the burden of limited organ supply but 
eventually may challenge heart transplantation as the standard of care for AHF patients 
(Kirklin et al., 2012).  
Purpose 
 There is limited literature exploring the LVAD patient experience and adjustment 
to the device. Additionally, no known studies have explored if there is variation in how 
patients construct the impact on daily life and self-care or the LVAD patient experience 




LVAD patient experience, describe how patients construct the impact of the LVAD on 
daily life and self-care, and compare the findings between BTT and DT patients. The 
following research questions were posed: (1) How do patients living with an LVAD 
perceive the comprehensive experience? (2) What are the perceived issues and challenges 
regarding LVAD adjustment? and (3) Do LVAD patients adjust differently according to 
the self-reported treatment trajectory (BTT or DT)? It is imperative to understand how 
BTT and DT LVAD recipients construct the patient experience in order to provide 
patient-centric education for each group and promote optimal adjustment. 
Methods 
The study used a general qualitative methodology with an interpretative approach 
to explore the perspectives of LVAD patients and achieve the aims of this research 
(Crabtree & Miller, 2009).  
Setting 
The setting for this study was the Texas Medical Center (TMC) located in 
southeastern Texas. The TMC is the largest life sciences location in the world. It is home 
to 54 institutions, five of which implant LVADs. Pioneering heart surgeons from the 
TMC have profoundly contributed to the development and advancement of the LVADs. 
Participant recruitment and sampling occurred in the outpatient clinic of two LVAD 
programs within the TMC, Baylor St. Luke's Medical Center (BSLMC), and Memorial 
Herman-Texas Medical Center (MH-TMC). The two programs collectively implant 
approximately 150 LVADs annually and manage routine care for over 300 patients. 
The University of Texas Health Science Center at Houston, Cizik School of 




interviews due to clinical neutrality. If participants were unable to access the CSON or 
had scheduling conflicts, interviews occurred at the LVAD clinics coinciding with a 
routine clinic visit. 
Participants and Sampling 
Participants were men and women currently implanted with an LVAD. The 
inclusion criteria for participants with LVADs were (a) adult participants (age > 18 
years), (b) able to speak English, (c) currently living with a HeartMate II, HeartMate 3, or 
HeartWare device, and (d) greater than one-month post LVAD implantation. Sampling 
began with a purposeful sampling of LVAD outpatients from the two LVAD centers 
(Polit & Beck, 2017). As recruitment began to become saturated among a specific 
typology (i.e., BTT), the researcher used theoretical sampling to explore further the 
differences and similarities between the two typologies in question (BTT and DT) (Polit 
& Beck, 2017). To achieve variation within the sample, extreme or deviant case sampling 
and typical case sampling were also utilized (e.g., participants with challenging 
postoperative courses, device malfunctions, and replacements) (Green & Thorogood, 
2004; Polit & Beck, 2017). Participant sampling and recruitment ceased once data 
saturation was reached. 
Data Collection 
Data was collected using open-ended group, and one-on-one interviews using a 
semi-structured interview guide (Table 1). The guide was developed based on the 
conceptual framework, Callista Roy's Adaptation Theory (Roy, 2009), a grand theory that 
focuses on the individuals’ ability to adapt with the internal and external environment. 




Key questions included (a) How did you first learn about an LVAD? (b) How the LVAD 
impacted you physically. Psychologically? (c) Tell me about how the LVAD has 
impacted your ADLs. (d) How has the LVAD impacted your self-concept? (e) How has 
the LVAD has impacted your personal and professional roles (e.g., parent, spouse, 
employee, student)? As data analysis and collection continued, interview questions 
evolved in order to explore further emerging themes or concepts related to the adaptation 
process. Interviews were audio-recorded with participant written consent, and field notes 
were collected. The recordings were transcribed verbatim by a professional 
transcriptionist and verified for accuracy. All data were de-identified in order to protect 
confidentiality. 
All LVAD participants completed a demographic survey. Demographic 
characteristics collected included self-reported age, race, gender, marital status, 
educational level, employment status, household income, LVAD device type, the reason 
for LVAD (e.g., BTT or DT), and length of time with LVAD.  
Procedures 
The UTHSC Institutional Review Board approved the study before data collection 
initiated. Study flyers were placed in outpatient clinic rooms or distributed by LVAD 
clinical providers at both AHF clinics. Onsite recruiting and screening for eligibility 
criteria also occurred at both clinics. If individuals met inclusion criteria and expressed 
interest in participating in the study, written informed consent was obtained and self-
reported demographic data were collected. Participants then scheduled an appointment 
for an interview. Other participants who learned of the study from a study flyer contacted 




CSON or one of the AHF clinics. These participants provided written informed consent 
and completed the demographic survey before the interview initiated.  
Interviews were conducted in a quiet, comfortable location within the UTHSC-
CSON or LVAD clinics. Participants from both LVAD centers were scheduled for group 
interviews according to self-reported LVAD indication (e.g., BTT or DT) in order to 
attain homogeneity and allow participants to speak openly concerning their experiences. 
Faculty from the UTHSC-CSON with expertise in qualitative research observed three of 
the interviews and provided feedback to ensure consistent data collection techniques. 
After the interviews, participants received a small honorarium ($10 gift card) and a 
parking voucher.   
Data Analysis 
 Data analysis began shortly after data collection was initiated and continued 
throughout the data collection process. All audio recorded interviews were transcribed 
verbatim by a professional transcriptionist. Transcripts were proofread in order to 
develop a comprehensive understanding of the data and validate the transcription. The 
research team used peer debriefing and discussion to ensure credibility and dependability. 
Field notes, reflexive journaling, and an audit trail were collected to ensure transferability 
and confirmability (Lincoln & Guba, 1985).  
Participants were assigned a study identifier and de-identified data (e.g., 
transcripts, field notes) were obtained. Hard-copy data was secured and stored behind a 
double lock at the UTHSC-CSON. Electronic data was stored within a secure online 
database (REDCap) behind UTHSC-CSON encrypted drive and firewalls. Transcripts 




qualitative research (Scientific Software Development GmbH, 2017) to iteratively 
identify codes and a codebook developed. Themes, constructs, and a model were 
developed with recursive analysis and peer debriefing. Sampling continued until a good 
depth and repetition of themes were reached and little new information emerged. 
Findings 
Sample Characteristics 
The sample consisted of 13 men and seven women (Tables 2 and 3). Eight 
identified as black, ten white, and two as more than one race (black/white and 
white/another race not indicated). The participants had been supported by LVAD therapy 
for a mean of 35.6 months and ranged from three months to 146 months. Three of the 
participants had experienced LVAD complications requiring device replacement. Two 
participants had two consecutive pumps, and one of the participants required two pump 
exchanges resulting in a total of three LVAD devices over an 11-year time frame (two 
HeartMate II devices and one HeartWare device).  
At the time of data collection, HeartMate II devices supported five of the 
participants, HeartWare devices supported 12 participants, and HeartMate 3 devices 
supported three participants. Fourteen participants self-identified as bridge to transplant 
(BTT) (70%) LVAD recipients and six identified as destination therapy (30%) LVAD 
recipients. Of the participants that reported BTT, eight of the participants self-reported 
being listed for a heart transplant and six of the participants self-reported not listed for a 
heart transplant (Table 3). Most of the participants were married (55%), had some 
college, but no degree (40%), were retired (45%), and reported an income of less than 




Living with the LVAD: A Second Chance at Life 
In order to describe how LVAD patients construct the impact of the LVAD on 
daily life and the holistic self, a linear and sequential model was developed (Figure 1). 
The model depicts the three separate phases representing the LVAD patient experience, 
(1) illness perception, (2) LVAD adjustment, and (3) health aspirations. Each phase 
directly influences the phase(s) that follow. Before receiving the LVAD, participants 
recalled aspects of living with AHF and what it was like to first learn about LVAD 
therapy. The perception participants of the illness process before LVAD directly impacts 
how one perceives LVAD adjustment.  
Following the LVAD implant, participants described six components that 
impacted LVAD adjustment and the holistic self. The six components include (1) 
physical ability, (2) caregiver dependence, (3) self-care, (4) roles, (5) LVAD public 
perception, and (6) connection. The factors that participants discussed as the most 
relevant following LVAD implantation included one's physical ability and caregiver 
dependence. As time progressed and recipients progressed through the LVAD adjustment 
process, self-care and roles became important, followed by LVAD public perception and 
connection.   
The LVAD recipient's perceived LVAD trajectory (BTT or DT) influenced the 
LVAD adaption process. It is this perception that influences all aspects of LVAD 
adjustment but does not differ based on implant indication. The holistic person, as well as 
health aspirations, were most heavily influenced by the perceived treatment trajectories 
and differed based on perceived BTT treatment trajectory or perceived DT treatment 




motivations for heart transplantation. Those that reported DT described future aspirations 
of LVAD device longevity (e.g., support on LVAD therapy for more than ten years). 
Overall, both BTT and DT participants reported various inconveniences associated with 
living with an LVAD; however, they also expressed the LVAD was life-sustaining. Most 
participants expressed heartfelt gratitude for a second chance or "New Lease on Life." 
Illness Perception 
Illness perception includes descriptions of the AHF disease process and symptoms 
before receiving the LVAD. Additional key findings worth noting included: experiences 
regarding AHF care from community providers (e.g., local primary care providers or 
cardiologists not specializing in AHF treatment options [LVAD or heart transplant]), 
initial introduction to an LVAD, having a limited choice regarding the acceptance of the 
LVAD, and the surgical recovery following the LVAD implant. Table 4 provides 
participant exemplars. 
Advanced Heart Failure (AHF). 
Almost all participants described significant AHF symptoms (e.g., shortness of 
breath, edema, orthopnea, dyspnea on exertion, and limited mobility). Participants 
emphasized being able to walk only a short distance without having to stop and sit down. 
The symptoms also limited the participants' ability to perform ADLs. Participants' 
symptom burden with AHF was directly influential on the participant's expectations post-
surgical implant of the LVAD.    
Community Care. 
Many participants noted positive experiences regarding initial AHF care by 




Others noted frustration in delayed referrals for AHF treatment or "not being heard" by 
providers in the community, requiring the participant to seek advanced therapies 
independently. One female participant reported instructions from her health care provider 
to lose weight and that would resolve all her AHF symptoms would resolve. Her 
concerns were ignored despite her persistence that something was wrong aside from her 
increased weight. Participants also reported participants also discussed a lack of 
community awareness of LVADs. Many of the participants had very limited or no prior 
knowledge of LVAD therapy. Participants that were less familiar with the LVAD before 
receiving the device experienced increased challenges in the LVAD adjustment phase. In 
contrast, one participant that received the LVAD after her bother received a device. She 
described a seamless transition through the phases of LVAD adjustment after witnessing 
her brother's experience. 
Introduction to an LVAD. 
All participants discussed thorough education about the LVAD by clinical 
providers (e.g., physicians, LVAD coordinators); however, the time from initial 
introduction to device implant varied significantly among participants. A couple of the 
participants noted being supported by medical therapy for approximately one to three 
years before receiving the LVAD. Other participants described being admitted to the 
hospital for the LVAD either immediately or within days after the initial AHF clinic visit. 
The participants with extended time between first introduction and LVAD implant 
reported researching LVADs through social media (e.g., Facebook groups, online chats, 
YouTube), appeared to more readily adjust than those that had a short period between 





During AHF symptoms, participants expressed having a limited choice when 
having to decide on an LVAD; however, participants recognized that death was a choice. 
Several participants verbalized being comfortable with the thought of death, however 
opting to give the LVAD a try. A female respondent discussed being very reluctant to 
receiving the LVAD; however, after discussing in-depth with her cardiologist and 
thinking on aspects of her life that she valued (e.g., family, grandchildren), she opted to 
proceed with an LVAD. Male and female participants alike reported being in the hospital 
and acknowledging they would die or discharge on hospice if they chose not to receive 
the LVAD. Patients that self-reported DT often felt they had a limited choice regarding 
treatment options (e.g., LVAD vs. heart transplant). Some participants adjusted well, 
regardless of having a limited choice in treatment options. Others, most commonly DT 
participants, did not adjust optimally due to limited choice.  
Cardiac Surgery and Recovery. 
Several participants described anxiety related to anticipation of a sternotomy, 
cardiothoracic surgery, waking up with an endotracheal tube inserted, and being 
mechanically ventilated. Multiple participants described anxiety and stress when 
recounting aspects of the cardiac surgical recovery (e.g., intubation and ICU delirium). 
Some respondents described a lack of pre-surgical knowledge of intubation. Additional 
respondents expressed fear and great distress recalling waking up with the breathing tube 
inserted and not being able to communicate effectively. Multiple participants vividly 
recalled the trauma of intubation and surgical recovery despite how long the recipient had 





LVAD adjustment refers to an individual’s ability to adapt or incorporate the 
LVAD into daily life. Both BTT and DT participants described a similar LVAD 
adjustment process. When describing adjustment, participants described six components 
of LVAD adjustment that progress from left to right in order of importance (e.g., moving 
from LVAD implant towards the Future): (1) physical ability, (2) caregiver dependence, 
(3) self-care, (4) roles, (5) LVAD public perception, and (6) connection. 
Overall, participants all discussed successfully achieving LVAD adjustment. 
Participants noted challenges related to adjustment, and the time required for getting back 
to normal varied among participants from a couple of weeks to approximately two years. 
Components of LVAD Adjustment.  
  This study identified six specific components of LVAD adjustment, as previously 
described. Each component is independent of the other components, yet directly 
influences the holistic self. Components can influence one another through the 
transformation of the holistic self. Table five presents participant exemplars regarding the 
specific components of LVAD adjustment. 
Physical Ability. 
Physical ability refers to one's ability to perform a physical act. Many participants 
described a noticeable difference in their physical ability very quickly after the LVAD, 
while others noted a gradual improvement over many months. Because of the dramatic 
physical impairments before the LVAD, often, physical improvements were one of the 




respondents described having increased energy. A few participants noted having this 
increase in energy as early as a couple of days to weeks post-operatively. 
In contrast, others reported it taking one to two years to return to what the 
recipient considered 100%. Others discussed being able to do significantly more activities 
(e.g., cooking, washing the dog, mowing the grass, planting a garden) than before 
receiving the LVAD. One participant reported a very lengthy post-operative recovery 
lasting over ten months. This decrease in acute physical ability post-LVAD negatively 
impacted adjustment. The participant noted that while he was still improving in his 
strength, he still noted remarkable differences from the participants in the group 
interview. 
Caregiver Dependence. 
Despite improvements in physical ability, participants initially required assistance 
from caregivers. Caregivers varied, one participant described his wife, a nurse, being his 
primary care provider due to her healthcare background. Others noted parents, spouses, 
or multiple family members collectively taking on the caregiver role. As time progressed 
with the LVAD, many participants described gaining more independence and requiring 
little help from a caregiver, and some eventually achieved independence. One participant 
reported living completely alone and successfully managing her LVAD for over three 
years with a limited support system.  
Self-Care. 
 Self-care refers to the behaviors performed in order to improve well-being, 
preserve health, maintain physical ability, and emotional stability (Riegel et al., 2012). 




Multiple participants reported an acute awareness of the driveline and battery 
cables. This acute awareness of the external equipment often became a social barrier as 
participants described a fear of having the battery cables or driveline disconnected in 
large crowds. Participants also described difficulty managing the equipment in stadium 
seating for professional sporting events (e.g., baseball) or entertainment venues (e.g., 
symphony, concerts). 
Aside from the external LVAD equipment, the device weight was the next most 
impactful aspect of device management. One participant who received his device soon 
after being introduced to the device described being very surprised about the weight of 
the external equipment. Many participants noted the device weight limited exercise 
tolerance and limited ADLs.  
Due to the inability to get the LVAD wet, LVAD recipients had to take 
precautions to ensure the driveline exit site and external equipment stayed dry when 
performing hygiene. Securing the driveline exit site and equipment could take up to 30 
minutes to an hour and required assistance from a caregiver. Due to the complex process 
of taking a shower, many participants described taking "hospital type" sponge baths. 
Universally, the women reported significant inconveniences with clothing 
selection. Women were also overall more concerned with the bag and accessories used to 
manage the external LVAD equipment. One male participant, currently employed as a 
law enforcement detective, expressed concerns regarding clothing and device wearables. 
He reported that despite modifications, most clothing made it extremely complicated for 




tactical shirt used by many LVAD recipients, the controller overheated while performing 
routine job duties due to prolonged exposure to the heat.   
 Participants described inconveniences related to sleep and the management of the 
external LVAD equipment. The most common inconvenience reported was positioning 
the LVAD in order to be comfortable for sleep. One participant expressed anxiety and 
fear of the device controller falling off the bed in the middle of the night and pulling the 
driveline out of his chest. Another participant reported sleeping on batteries, despite 
medical recommendations to sleep on AC power, due to the necessity to get up and 
urinate throughout the night.  
Participants described various practices and clinical recommendations regarding 
driving. Many participants described the return to driving and even completing some 
long-distance trips by care, while others noted returning to driving but only in a limited 
area. Others reported not returning to driving at all due to medical recommendations. One 
participant highlighted that with the LVAD, the lap belt now sits appropriately across his 
upper thighs rather than incorrectly across the abdomen.   
Participants noted complications regarding recreational and leisure activities. Due 
to the inability to get the LVAD equipment wet, almost all participants reported 
inconveniences and frustrations with not being able to participate in water activities. 
Other participants reported inconveniences and frustrations regarding travel. One female 
reported feeling uncomfortable and embarrassed about going through airport security. 
Other participants report abstaining from or limiting travel due to being temporarily 
inactivated from the transplant waiting list while greater than four hours away from the 





Roles include the duties that someone has or is expected to have (“Role definition 
in the Cambridge English Dictionary,” n.d.). Participants report changing roles that often 
started due to AHF. Participants reported decreased ability to participate in family 
activities or perform ADLs around the house. Often these roles and ability to contributed 
to one’s family improved after the LVAD. A woman described the inconveniences 
regarding the LVAD equipment and her interactions as a grandmother. At the same time, 
two gentlemen discuss the frustration of not being able to care for grandchildren as 
previously before the LVAD. 
Several participants reported the loss of employment and having to go on 
disability or retire early, while others discussed how the LVAD was preventing a return 
to employment. In contrast, participants that reported higher education were often able to 
return to employment. These participants often had jobs that did not require heavy lifting, 
pose infection risks, and flexible hours to accommodate clinic appointments. 
LVAD Public Perception. 
LVAD public perception refers to how one perceives people in general, or people 
in a country or community, think about the LVAD or the impression they have of the 
device. The LVAD bag and accessories were also significant for how women were 
publicly perceived and how the weight was physically supported. One woman selected to 
carry her LVAD with the controller and batteries strapped around her chest across her 
sternum. The unique positioning of her LVAD equipment served as a function to help 
support the weight of the device despite outward appearance. Due to the positioning of 




LVAD as a threat (e.g., bomb). While some participants described a disregard to the 
visibility of the external LVAD equipment and public perception, others reported concern 
for others perceiving the LVAD was of value and the possibility of attempted theft. 
Public misperception was especially true for participants that carried the LVAD, where it 
was outwardly visible and used public transit.    
Connection. 
Connection is defined as "The energy that exists between people when they feel 
seen, heard, and valued; where they can give and receive without judgment; and when 
they derive sustenance and strength from the relationship" (Brown, 2012). Participants 
expressed a connection with clinical providers when they felt seen, heard, and valued. 
When waiting for an LVAD, participants often reported connecting to LVAD patients 
and gaining insight and strength to pursue and adapt to the LVAD. Once implanted with 
the LVAD, participants often derived sustenance from friendships and activities with 
other LVAD recipients. It was in these relationships that participants expressed the ability 
to share without being judged. Lastly, participants valued connecting with AHF patients 
awaiting an LVAD or people in the community that expressed interest in learning more 
about the LVAD.   
Holistic Person. 
The LVAD participant as a holistic person involves being aware of the entire 
being and understanding all the components that contribute. All the identified and 
described areas of LVAD adjustment identified in Figure 1 contribute to the holistic 
person. One of the predominant topics of describing oneself was the desire for normalcy 




specific tasks (e.g., return to golf, grocery shopping, returning to work). Participants also 
described how the LVAD prevented specific normal activities (e.g., driving, water 
activities). 
Participant Perceived LVAD Trajectory. 
Within the theme LVAD Adjustment, two trajectories emerged: Perceived BTT 
LVAD Trajectory and Perceived DT LVAD Trajectory. The concepts were overarching 
influences on the holistic person and the six components of adaptation depicted in Figure 
1.  However, the trajectory was perceived, either BTT or DT demonstrated the most 
significant influence on the holistic person and health aspirations.  
Participants that self-reported BTT grappled their holistic self. Internal issues 
such as the statistical odds of receiving a heart transplant, perceived disabilities, the 
realization that someone must die in order for the LVAD recipient to receive a heart 
transplant, equity regarding organs, beliefs regarding artificial life support, and 
spirituality regarding life and death.  
The holistic self of participants that did not meet transplant criteria, destination 
therapy, struggled with inadequacies regarding ineligibility for a heart transplant (e.g., 
age, illicit substance or tobacco use, or BMI). One DT participant reported confidence in 
her decision, "it was my choice," to proceed with the LVAD for the duration of her life.  
Participants that perceived they were BTT, whether currently on the transplant list 
or not, discussed factors that motivated them to the goal of a heart transplant, while those 
that perceived themselves as DT discussed the desire for device longevity and outliving 






 Health Aspirations referred to hopes or ambitions of achieving something specific 
to their health. Overall, participants' initial health aspirations focused on the tasks 
necessary for survival. Many described acute awareness that without the LVAD, death 
was imminent. 
Motivation for Heart Transplant.  
BTT and DT participants' responses differed regarding health aspirations of living 
with AHF treatment (i.e., LVAD). BTT participants listed for heart transplant reported 
specific reasons for the pursuit of a heart transplant. One individual expressed that he was 
a public speaker and felt that his story would be complete with the transplant. Another 
reported that he could live for the remainder of his life with the LVAD; however, he was 
on dialysis, which significantly decreased the quality of his life. In order to receive a 
kidney transplant, he would also need a heart transplant.   
LVAD participants that were not on the transplant list expressed aspirations of 
achieving heart transplant criteria (i.e., weight loss, achieving a period tobacco-free) and 
the intent to continue to the transplant list. One participant reported her struggles to lose 
weight, ultimately delaying her from transplant listing, and attributed such difficulties to 
the possibility that she was not entirely comfortable with someone dying for her to 
receive a heart transplant 
Device Longevity.  
Due to the relatively new advancements in LVAD technology, the comprehensive 
longevity of the LVAD is unknown. Currently, some patients have been supported by a 




complications with one pump, the pump can be exchanged for a new device. LVAD 
replacement is often a relatively uncomplicated surgery that generally yields favorable 
results. DT participants expressed health aspirations of extended life on the LVAD (i.e., 
greater than ten years) or technologic advancements that could replace the current LVAD 
(i.e., future generation LVAD pumps). One participant discussed how his heart was 
overall in great condition; therefore, the pump should last a very long time (e.g., greater 
than ten years).   
Living with an LVAD is Inconvenient but Life-Sustaining 
 The single overarching theme of the study reported by participants; living with an 
LVAD is inconvenient, but life-sustaining. Participants constructed the LVAD patient 
experience in three phases: (1) illness perception, (2) LVAD adjustment, and (3) and 
health aspirations. Participants described the LVAD adaptation process in greater detail 
with emphasis on six components: (1) physical ability, (2) caregiver dependence, (3) self-
care, (4) roles, (5) LVAD public perception, and (6) connection. Each of these 
independent components of LVAD adaptation impacts the holistic person and vice versa. 
The independent components do have the potential to influence other components as it 
influences and changes the holistic person.   
 Both groups of participants (BTT and DT) constructed similar phases of how the 
LVAD impacted daily life and self-care (e.g., illness perception, LVAD adjustment, 
health aspirations). Perceived LVAD trajectory begins at the time of LVAD implant and 
influences LVAD adaptation and the respondents' health aspirations. Participants who 
identified as BTT expressed individual and specific motivations for pursuing a heart 




their life (DT) reported hope and desire to live greater than ten years with the LVAD 
technology. The overarching theme acknowledged that living with an LVAD certainly 
has its challenges; however, it allows for the patients to experience a second chance at 
life. 
Discussion 
Living with the LVAD: A Second Chance at Life 
Understanding the process in which LVAD recipients construct the overall patient 
experience is essential to optimizing LVAD adjustment resulting in improved patient 
outcomes. The model (Figure 1) depicts the three phases described by participants in this 
study.   
Previous studies have identified components of LVAD self-care (Casida et al., 
2011; Chapman et al., 2007; Kato et al., 2014; Overgaard et al., 2012); however, this 
study notes the emphasis on individuals striving to achieve independence in caring for the 
LVAD. For example, one participant reported living alone with the LVAD for over three 
years. The study also identified inconsistencies in patient-perceived LVAD self-care 
instructions or requirements (e.g., dressing change frequency and supply process, driving 
allowances, and dietary recommendations). The researcher observed these inconsistencies 
among participants within the same LVAD center in addition to the two separate LVAD 
centers. 
 Previous research highlighted the phases in which LVAD self-care occurred: (1) 
early home adaptation and (2) late home adaptation (Casida et al., 2011) and noted the 




This study expanded on the components of LVAD adjustment and highlighted the 
importance of roles, LVAD public perception, and connection in the adaptation process.  
Previous studies highlighted the desire for normalcy. In these studies, participants 
described normalcy as incorporating the LVAD into ADLs the recipient valued or 
looking normal in public. (Alonso et al., 2018; Casida et al., 2011; Chapman et al., 2007; 
Hallas et al., 2009; Marcuccilli et al., 2013; Ottenberg et al., 2014; Overgaard et al., 
2012; Sandau et al., 2014 ). In this study, participants emphasized specific activities by 
which participants measured normalcy (e.g., golf, grocery shopping) rather than public 
appearance.  
Clinical Impact Trajectory vs. Patient Perceived Trajectory 
  All LVAD recipients are assigned a clinical implant indication based upon the 
recipient's ability to meet transplant criteria. Recipients must often wait a minimum 
period of six months post LVAD implant in order to allow for surgical recovery before 
heart transplant listing. Additional factors (e.g., BMI, substance abuse, health care 
compliance, limited social support) may delay an LVAD recipient's activation on the 
heart transplant list. The study identified a possible disconnect regarding clinical the 
clinical implant trajectory and the self-reported LVAD trajectory and self-reported heart 
transplant listing status. Fourteen participants self-identified as BTT candidates; however, 
only nine self-reported actively on the list for a heart transplant. This discrepancy 
presents the need for further research as to why participants would perceive they are BTT 





Future Implications  
Clinical Practice  
The model developed in this study identifies six modes related to the LVAD 
adaptation process. In order to promote adaptation, clinical providers should be 
knowledgeable regarding the various modes of each LVAD patient’s adjustment 
processes. Clinical providers can assist patients through the various modes of adaptation 
identified (e.g., physical, caregiver dependence, device management, roles, LVAD public 
perception, and connection). For example, an understanding of a patient’s caregiver 
dependence allows the LVAD team to provide patient-centric education regarding the 
care of the device. Patient-centric education is critical if the patient has limited social 
support or will be living alone. Additionally, providers can expedite teaching the patient 
to perform LVAD dressing changes independently and monitor for clinical signs of 
infection if the provider knows there is a strong desire to be independent and has a fear of 
being a burden to caregivers. Also, younger LVAD patients that are planning to assume 
the roles of college students may need special considerations regarding clinic 
appointment scheduling in order to accommodate classes. 
In this study, participants discussed a strong desire to connect with clinical 
providers and other LVAD patients. Several of the participants described strong existing 
connections with LVAD patients, reporting frequent contact and encouragement along 
with participating in social activities together (e.g., golf, travel, and social activities). The 
connection among LVAD patients provides the opportunity to express challenges and 
frustrations as well as receive advice and recommendations in a safe, nonjudgement 




connect in order to establish friendships, exchange information, provide peer support, and 
connect with others experiencing LVAD adjustment.  
Patient Education 
Overall, participants noted satisfaction concerning LVAD education and 
preparation for the patient or caregiver to care for the device upon hospital discharge. 
However, several participants mentioned a lack of preparation and even traumatic 
experiences regarding aspects of cardiac surgery (e.g., intubation, intensive care unit 
psychosis, post-surgical pain). Providers have the opportunity to optimize LVAD patient 
education and include information regarding the cardiothoracic surgery, intubation, and 
post-operative recovery.  
Additional areas for patient education include how to modify clothing and LVAD 
accessories (e.g., belts, vests, pants) to accommodate a patient's various activities. Male 
and female participants also noted frustration regarding wearing the LVAD and external 
equipment. It often takes a lengthy period and much trial and error for patients to achieve 
personal ways to wear or carry LVAD equipment. This process has the potential to delay 
or frustrate participants as they move through the LVAD adaptation process. Often 
patients do not have access to try various ways to wear or carry LVAD equipment before 
purchasing products.  LVAD centers should consider investing in a variety of LVAD 
equipment and accessories for education, and so patients may try on at clinic visits. 
Optimizing the LVAD adaptation process has the potential to improve LVAD patient 
satisfaction with the device and increase stabilization of the LVAD, thus preventing 






 The findings of this study present several opportunities for further research. This 
study identified the potential disconnect between the clinical LVAD implant indication 
and the patient perception of the LVAD treatment trajectory. Of the participants, six 
(30%) self-reported BTT, however, indicated they denied current heart transplant listing. 
Research is needed to determine if participant perception aligns with the LVAD clinical 
team perception of the participants’ perception and what factors are hindering 
participants from being listed for transplant. This study also identified inconsistencies 
regarding clinical care requirements (e.g., medication adherence, risks for infection) 
regarding heart transplantation. For example, some participants discussed returning to 
activities after heart transplantation that clinical providers might feel pose an increased 
risk of infection (e.g., parks, activities with large crowds). Participants expressed the 
desire for a heart transplant due to the ability to have increased energy, improved 
tolerance to the heat, and extended life greater than ten years. Despite perception, there 
are no guarantees that clinical outcomes after transplant will achieve the above. There is a 
need to fully understand the LVAD patient’s perspective regarding motivation for heart 
transplantation in order to establish realistic expectations. 
Employment often fulfills one’s ability to contribute financially to one’s 
household as well as provides a purpose for individuals. Limited research is available 
regarding employment with an LVAD device. One study describes the challenges with 
assisting younger LVAD patients to find occupations conducive to the LVAD as well as 
helping other transition from the sick role into meaningful employment (Overgaard et al., 




AHF symptoms. Participants also varied in responses regarding an ability to return to 
employment. Participants noted being employed previously in positions that presented 
challenges to returning due to physical requirements (e.g., lifting heavy objects, driving 
heavy machinery) and risks for driveline infection (e.g., exposure to weather, heat). 
Participants who expressed the ability to return to work possessed similar occupational 
characteristics: work that could be completed remotely from home. These flexible 
schedules can accommodate frequent healthcare clinic visits and requiring little to no 
physical requirements. However, occasionally participants who identified prior 
occupations that met the above criteria did not return to work. It is essential to further 
explore motivating factors regarding obstacles and barriers related to employment after 
the LVAD. LVAD clinical providers should have an understanding of this vital 
component of LVAD adjustment. 
The study also depicts discrepancies among patient perceptions regarding 
activities such as support system, driving, dressing change frequency, anticoagulation 
management. Often these activities or inconveniences create frustration and more 
significant challenges regarding LVAD adaptation. Incongruences regarding modes of 
LVAD adjustment included the following: (a) living independently vs. being required to 
have continual care provide (e.g., having to relocate to live with family), (b) center 
recommendations regarding driving (e.g., physician approval to return to driving vs. 
inability to drive at all), (c) frequency of driveline dressing changes (e.g., daily vs. 
biweekly or weekly), (d) dietary recommendations (e.g., ability to eat vitamin K rich 




monitoring (e.g., home INR monitoring). Further research and standardization of best 
practices between LVAD centers could profoundly impact the LVAD adaptation process. 
Strengths and Limitations 
 This study provided, to our knowledge, the first qualitative study to explore 
LVAD adaptation and the patient perceived LVAD implant indication among participants 
from two LVAD centers. Using study participants from two centers allowed researchers 
the ability to confirm responses among participants and increase generalizability. The 
semi-structured interview guide used Roy’s Adaptative Model (RAM) (Roy, 2009) as a 
theoretical structure served as a strength of the study allowing the researchers to explore 
the holistic approach to LVAD adjustment. The concepts derived from the study (e.g., 
caregiver dependence, device management, roles, LVAD public perception, connection, 
and holistic person) varied from that traditionally described in RAM, the researchers 
were able to develop a model more specific to the experiences of LVAD participants 
regarding the adjustment experience.    
The sample attempted to capture a similar demographic representation of the 
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), 
national LVAD data registry, in order to increase study applicability (e.g., 46% DT and 
54% BTT in 2011-2014)(Kirklin et al., 2015). However, more participants identified as 
BTT than one would anticipate based on the INTERMACS registry. Despite these 
participants identifying as BTT, they self-reported they were not active on the transplant 
waiting list, leaving room to question if these participants may have received an LVAD 




A limitation of the study included a lack of confirmation regarding LVAD 
implant indication, current transplant listing status, and specific factors contributing to 
heart transplant ineligibility. Additionally, participants self-selected to be interviewed, 
thus their overall health may be more optimal than other LVAD patients. Finally, the 
sample consisted of BTT and DT participants; although we noted overall consistency in 
responses regarding LVAD adjustment among the groups, other studies may discover 
different findings.   
Conclusion 
Roles, public perception, and connection were significant to LVAD patients but 
are often not addressed in this population. Results provided a basis for topics for further 
exploration and study, such as how patients adapt to the LVAD without caregiver 
support. This study identified the need for opportunities for LVAD patients to connect 
with clinical providers and participate in activities with other LVAD patients. Topics 
identified for further education among LVAD patients included the following: post-
surgical care, showering/bathing, clothing, equipment options, travel, navigating security, 
and an annual refresher for managing clinical complications. Finally, results provided a 
basis for further qualitative exploration regarding the patient perspective of challenges in 






Semi-structured guide for group and individual interviews. 
Opening:  
1. Please share your first name and how long you have had your LVAD, and if you 
have ever had your LVAD replaced. 
 
Transition: 
2. How did you first come to learn about an LVAD? 
 
Key Questions:  
3. Can you share how the LVAD has impacted you physically? Psychologically? 
4. Tell me how the LVAD has impacted your self-concept both positively and 
negatively? 
 
5. How did your family and friends initially respond to the LVAD? 
6. What are some of the "roles" that you have among your family and professionally 
(e.g., spouse, family member, parent, financial provider, caretaker)? Can you 
share how the LVAD has impacted these roles?  
 
7. Tell me about how the activities that require assistance from someone because of 
the LVAD? 
8. How has the LVAD impacted your activities of daily living? 
9. How would it impact your life if you knew you were going to live with the LVAD 
for the rest of your life? 
 
Ending:  
10.  After having the LVAD for a period now, what information do you wish you 
would have known before receiving the LVAD?  
 
11. What information would you share with someone thinking about getting an 
LVAD to best prepare them? 
 
Note. Based on the interview structure outlined by (Crabtree & Miller, 2009) and 





Sociodemographic Characteristics of Participants 
 
Characteristic Value (%) 
Age, mean 57 years 
Black or African American 
White 
More Than One Race 
8    (40%) 
12  (60%) 





7    (35%) 
13  (65%) 
Length of Time with LVAD 
< 1 year 
1 – 2 years 
3 – 4 years 
5 – 6 years 
7 – 8 years 
9 – 10 years 
> 10 years 
 
3    (15%) 
9    (45%) 
5    (25%) 
2    (10%) 
0    (0%) 
0    (0%) 
1    (5%) 





5    (25%) 
12  (60%) 
3    (15%) 




14  (70%) 
6    (30%) 
Marital status: 






3    (15%) 
11  (55%) 
1    (5%) 
4    (20%) 
1    (5%) 
Education level 
High school degree or equivalentd  
Some college, no degreee 
Bachelor’s degreef  
Master’s degreeg  
Professional degreeh 
 
5    (25%) 
8    (40%) 
4    (20%) 
1    (5%) 
2    (10%) 
Employment Status: 
Employed full timei  
Employed part-timej  





1    (5%) 
2    (10%) 
1    (5%) 
1    (5%) 
9    (45%) 




Unable to work 5    (25%) 
Household Income 
Less than $20,000 
$20,000 to $34,999 
$35,000 to $49,999 
$50,000 to $74,999 
$75,000 to $99,999 
>$100,000 
Did not disclose 
 
10  (50%) 
1    (5%) 
2    (10%) 
2    (10%) 
1    (5%) 
2    (10%) 
1    (5%) 
Note. N = 20. LVAD, left ventricular assist device; BTT, Bridge-to-transplant; DT, Destination therapy;  
a HeartMate II®; b HeartWare® (HeartWare, Inc., Framingham, MA); cHeartMate3® 
dHigh school degree or equivalent (e.g., GED), eSome college, no degree, f Bachelor’s degree (e.g., BA, 
BS), g Master’s degree (e.g., MA, MS, Med), h Professional Degree (e.g., MD, DDS, DV, Ph.D., EdD), 








Sociodemographic Characteristics and Recruitment Site of Participants 
Screening 
Site 












& Listing  
MH-TMC 64 Male Black HeartMate II®, a 5-6 yrs. Divorced Some collegee Retired $35,000 to 
$49,999 
BTT – (L)  
MH-TMC 55 Female White HeartWare®, b 1-2 yrs. Divorced High schoolf Unable to 
work 
< $20,000 BTT – (L) 
MH-TMC 70 Male Whited HeartWare®, b 1-2 yrs. Married Some collegee Retired < $20,000 BTT – (L) 
BSLMC 64 Male White HeartWare®, b 3-4 yrs. Married Professionalg Retired > $100,000 BTT – (L) 




BTT – (L) 
MH-TMC 62 Female Black HeartWare®, b 5-6 yrs. Divorced Bachelor’sh  Unable to 
work 
< $20,000 BTT – (L) 
BSLMC 54 Male Black HeartWare®, b > 10 yrs. Single  High schoolf Unable to 
work 
< $20,000 BTT – (L) 
MH-TMC 23 Female Black HeartWare®, b 1-2 yrs. Single  Some collegee Student < $20,000 BTT – (L) 
MH-TMC 39 Female White HeartWare®, b 1-2 yrs. Married Some collegee Employed PT $75,000 to 
$99,999 
BTT – (L) 
MH-TMC 62 Male White HeartMate II®, a 3-4 yrs. Married Some collegee Retired Did not 
disclose 
BTT – (NL) 
BSLMC 61 Male Black HeartMate 3®, c  < 1 yr. Divorced High schoolf Retired < $20,000 BTT – (NL) 
BSLMC 68 Male Blackd HeartWare®, b < 1 yr. Married Bachelor’sh Employed FT > $100,000 BTT – (NL) 
BSLMC 47 Female White HeartWare®, b 1-2 yr. Separated Some collegee Unable to 
work 
< $20,000 BTT – (NL) 
BSLMC 46 Female White HeartMate II®, a 3-4 yrs. Single Bachelor’sh Retired < $20,000 BTT – (NL) 
MH-TMC 49 Male Black HeartMate II®, a 3-4 yrs. Married High schoolf Unable to 
work 
< $20,000 DT 
BSLMC 66 Male White HeartWare®, b 1-2 yrs. Married Master’s i Retired $35,000 to 
$49,999 
DT 
BSLMC 74 Male White HeartWare®, b 1-2 yrs. Married Professionalg Employed PT > $100,000 DT 
BSLMC 73 Male White HeartWare®, b 1-2 yrs. Married Bachelor’sh Retired $50,000 to 
$74,999 
DT 
MH-TMC 66 Female White HeartMate II®, a 3-4 yrs. Widowed High schoolf Retired < $20,000 DT 
MH-TMC 34 Male White HeartMate 3®, c < 1 yr. Married Some collegee Unemployedj $50,000 to 
$74,999 
DT 
Note. N=20. LVAD, left ventricular assist device; S-R Implant & Listing, Self-Reported Implant Indication 
& Listing Status; MH-TMC, Memorial Herman – Texas Medical Center, Houston, TX; BSLMC, Baylor St. 
Luke’s Medical Center, Houston, TX; PT, Part-Time; FT, Full-Time; BTT, Bridge-to-transplant; (L), 
Listed for heart transplant; (NL), Not listed for heart transplant; DT, Destination therapy 
a HeartMate II®; b HeartWare® (HeartWare, Inc., Framingham, MA); c HeartMate 3® 
d Identified as More than one race, e Some college, no degree, f High school degree or equivalent (e.g., 
GED), g Professional Degree (e.g., MD, DDS, DV, Ph.D., EdD), h Bachelor’s degree (e.g., BA, BS), i 












"I went from gasping from breath and not being able to do 
a lot of things. Like, I could get out to the driveway and 
get my newspaper and come back in; that was it. That was 
my eight-hour job for the day." [Participant 26] 
"I developed breast cancer, and then the second year, I 
developed breast cancer again. And after that, the doctor 
did tell me that I will---with all the chemo, it weakened 
my heart and that eventually, I would be needing some 
kind of heart treatment or et cetera.” [Participant 3] 
 Community 
Care 
"They wouldn't listen to me. It was, you just need to lose 
the weight, and it'll fix itself.  You need to lose the 
weight; it'll fix itself. No, you're not hearing me, there's 
something wrong with me…This [LVAD] is 
unknown…Y’all deal with it every day. This [the LVAD] 
is a common occurrence for you all. For us, it's not…It's 
not out there at all [community LVAD knowledge]." 
[Participant 46] 
 Introduction 
to an LVAD 
“Well, first of all, they wanted me to decide. I had to go 
home for a couple of weeks and sit on the front porch and 
pray and figure it out with God, and I decided that it was 
the route to go because they [family] all wanted me to stay 
around a while.” [Participant 20] 
"And I thought I was just going in to ask questions you 
know, to—you know, just the routine…checkup thing—
just routine questions and stuff. And it didn't happen like 
that. The same day that I had the appointment with him, 
he put me in [hospitalized]. I mean, you know, he told me 
about the LVAD, but that very day he put me in. And 
total, after the operation and everything else, I was in 
there for a little over three months. That’s how I found out 
about it [an LVAD].” [Participant 42] 
 Limited 
Choice 
"I was told I need an LVAD; I was reluctant against it. 
And, [cardiologist], she had to talk me into getting one. 
So, after she made me realize things [my grandkids and 
my three boys], then I went on and agreed with it" 
[Participant 45]. 
“And then, of course, after I’m in the hospital and I’m 
going downhill pretty fast, you know, where they can’t get 
me out of AFib. And basically, I’m just really feeling bad. 
And then they tell me, well, we can do-, we can do this. 
And frankly, that’s your only choice. You know? So, it 




about going through with it because if it was my only 
chance, you know, I feel like I’ve got a lot of things that I 




"When they told me that they were going to have to put a 
tube down—a breathing tube down me, and I kind of 
freaked out, and she said, 'Oh, no, it will be removed 
before you wake up.' I was not prepared for what 
happened because all I knew—I didn't think about the 
tube—all I knew is that I couldn't breathe, nobody was in 
there, I couldn't remember where I was. There were no 
nurses, no family, no nothing. And, like I said, it was only 
a couple minutes at a time, maybe a couple of seconds at a 
time, that I would come to. But each time that it 
happened, it was the same thing. And honestly, I 
thought—that I was in some madman's house chained up 
because I couldn't move my hands. They were tied down. 




 “So, you know, I've gotten used to it now, and I've come 
to realize that, you know, I think, if I hadn't had got it, I 
don't think I'd been here now.  I don't know.  It's been an 




 “That was the whole point of getting the surgery.  That 
was the reason behind letting them put a steel titanium 
pump in my heart, getting on the golf course.  "And what 
about your family?"  I said, ‘Well, here it is, golf course, 
dog, wife, and kids.  Sorry.  That's priority.’” [Participant 
26] 
“The destination was not leaving the hospital alive 






LVAD adjustment components and participant exemplars 
Physical 
Activity 
“As far as the LVAD, I would say, within a week or two, I was doing 
pretty much anything I wanted to, even taking, you know, doing showers 
and stuff by myself, which I couldn’t before” [Participant 2]. 
“It made things easier for me to do around the house. So, it took a while 
for me to get back to my normal routines…maybe two years to get back 
at 100. Maybe two years…but I’m okay now” [Participant 45]. 
Caregiver 
Dependence 
“My wife has, kind of, taken the brunt of that just since being a nurse and 
doing most of every-, pretty much doing all of the actual care for the 
driveline, things like that.” [Participant 44] 
“That [LVAD] has changed my independence because they’re—my 
family, we’re a very close family, so, you know, they want to make sure 
that, you know, I’m in good hands at all times” [Participant 3]. 
Self-care "I don't like to be in a lot of crowds because of the wire hanging out 
[driveline], you know, because somebody could bump it, especially kids 
or stuff." [Participant 3] 
“I have two adapters at the house. I could sit and watch TV, or I can lay 
in bed and hook the adapter to it” [Participant 20]. 
"It's like 8 pounds or maybe 10, and it's a little difficult sometimes 
because you get tired easier. You're already running on a certain level, 
and then with this, it tacks onto it”[ Participant 32]. 
"My shower went from 30 minutes too, now, an hour, and hour and 20 
minutes by the time you wrap and make sure everything is just right and 
secure stuff" [Participant 37]. 
"Yeah, I—you know, that's a process that's just too time-intensive. It's 
easier for me to take a hospital-type bath, you know. I'll get in front of 
the sink and strip completely naked and do that all right there and 
shampoo my hair—the whole thing, and I've found that to be more 
efficient than encapsulating myself to take a traditional shower, you 
know. Yeah, it's a pain" [Participant 39]. 
"I can't wear a dress unless I get it special made. I can't wear heels…I've 
adjusted. You know, I just have to wear pants. I can wear a skirt and a 
top, anything two-piece. I can't wear like I said, a dress" [Participant 45]. 
"I've only driven once since having LVAD…Safety just because of 
having, then having to re-fix the sternum wiring once, going to have to 
go through that surgery again [transplant]. And also, just-, I’m a shorter 
statured guy. How close to the steering wheel I am, even to have a pillow 
there, it was very discomforting” [Participant 44]. 
Roles "Participant in family matters, get-togethers, doing stuff around the 
house, shredding, working, it just started to decrease and decrease and 
decrease, and then, once I got the LVAD, this all started coming back in 
place…So, it's, kind of, just rebuilding my life back slowly. And, I can't 




I can get out there and work for several hours, where I couldn't do 
anything hardly, not even walking to the car. I just had to stop, sit down, 
walking to the car" [Participant 20].  
"My grandkids, you know, they don't know. One of them, she was still 
hopping in my lap and stuff, you know. I just had to put her on this 
Participant e and let her know she can’t sit on my left Participant e” 
[Participant 45].  
“I didn’t realize what I had when I was so sick, but I had to retire several 
years before this came up” [Participant 2].  
“I can’t go back to the career I was just because it’s lifting heavy bags of 




“I don’t care what people say or look or how—about me, so I’m not that 
type of a person” [Participant 3].  
“As far as like going places, with all the crime and stuff, I’m so worried 
about [someone] thinking it’s a purse, you know, and yank it off my 
body.” [Participant 3]. 
"I've often wondered, I've often thought… Am I going to walk in a place, 
and they're going to be freaking out thinking I've got bombs on me 
because I've got a strap and these [batteries]." [Participant 42] 
Connection “When I go get my blood taken, in the store, anybody I talk to when the 
subject [LVAD] comes up, I tell them, ‘Do not hesitate to get it, whether 
it’s permanent or it’s getting in line for a transplant.’ I just, I would 
recommend to any and everybody for the LVAD now that I’ve been in it 
this long.” 
Holistic Self “The true reason [to receive the LVAD] was to get on the golf course. 
That’s my normal” [Participant 26]. 
"Before I had the surgery, I could go to the grocery store, and I could, 
one, pick out the groceries, or I could put the groceries on the conveyor 
belt. Or, if someone else did the first and second thing, I could put them 
in the car. If someone else did the first three things, then I could take 
them from the car to the house.  I could not do all four things…And, 
once I had the LVAD, I could do all four things, and the first time I could 
do all four things, I cried. I was just like, “I’m normal” [Participant 50]. 
"Not being able to, kind of, be myself, drive, things like that has felt like 






















“I told XXX [Cardiologist] two 
years ago, "I won't be getting an 
organ… I said, "Dr. XXX, I did a 
lot of gambling.  I've gambled all 
my life, for 17 years—sports 
gambling, I know the odds.” 
[Participant 26] 
"It's like getting out of your car, 
and you park in the handicap, and 
somebody starts yelling at you.  I 
used to carry the letter that says I'm 
on the transplant list.  But I can't 
quell their anger." [Participant 26] 
"For me, when I first, you know—I 
won't say when I first got it—after I 
got, after I was put on the 
transplant list, I just always come 
in here and cried to XXX 
[Cardiologist], because, somebody 
had to die in order for me to get a 
transplant, somebody has to lose 
their life.  I wish they could find 
another way that you could get a 
transplant, but I know they can't." 
[Participant 45] 
"A lot of people don't understand 
when you say that you question 
whether you want a transplant 
because—I'm a single woman.  I 
don't have any children.  I don't 
have any family.  There are people, 
and lots of them, that have 
situations where they have people 
that are dependent on them, and 
they're trying to get a heart, and 
that heart would benefit not just 
them, but the other people in their 
family, and impact other families.  
“I'm a public speaker.  My story's not 
complete.  I want to have a full story.“ 
[Participant 26] 
“I’m looking forward to it [heart 
transplant]…Maybe go back to work 
because I don’t like being at home. 
I’ve very active” [Participant 3] 
“Well, just to go fishing more, not 
necessarily swimming, but at least 
going fishing and just living in 
general…Just family altogether…If I 
get the transplant and if it agrees with 
me, I can see me, see us, you know, 
barbequing and having holidays meals 
and stuff, get-togethers, going fishing, 
maybe getting on the tractor and 
going, you know, a little bit in the 
pasture, different things like 
that…Enjoy animals. I mean, I do that, 
but right now, my wife is helping to do 
more part of my share." [Participant 
20] 
"My grandkids. My grandkids. I'll be 
able to go places with them, like go to 
the zoo, go to the park, you know, I'd 
just be able to enjoy them. Yeah. It'd 
be a big weight off of me…Because, I 
get tired, you know, from walking with 
it [LVAD] so long. Yeah. Like, I want 
to go to Disney World with them, but I 
can't take the heat. So, you know, all 
this medicine I'm on, I can't take the 
heat. And then, like, when you take 
different trips and stuff, you have to 
pack all this equipment and stuff. You 
know, it's not just like packing a 




And so, if you look at the big 
picture, if I got a heart, it just 
impacts me.  If they got a heart, it 
impacts them and their children and 
their children, and it goes on and on 
and on.  So, it's kind of, like who 
am I to take that away from them.  
So, now, if I say that out loud, 
some people get upset.  "Well, no.  
You deserve that too." [Participant 
50] 
"I thought I compromised my 
beliefs a little bit just because it 
was-, it's still a struggle thing and a 
machine, a mechanical thing is 
pumping my heart for me, 
basically.  And then, you know, 
after getting transplanted in a few 
years, even if it has you back on 
breathing machines and stuff like 
that..." [Participant 44] 
“I put, as far as living or dying, I 
put that in God's hands, and I put 
all the decision-making, medical, 
and educational part in the doctor's 
hands.” [Participant 20] 
to pack all your equipment, all your 
medicine, and stuff" [Participant 45]. 
 
DT  "Well, in my case, they wouldn't 
give me a heart, and the distilled 
version was, 'well, you've got 
uncontrolled diabetes,' which is 
actually not true.  I can routinely 
keep it under 200, routinely.  And, 
sometimes, if I'm really diligent, at 
100.  But what they can't tell you or 
won't tell you is, you're too old.  
Because they'd have the old people 
union on them, right?  There'd be 
pitchforks out front—they'd be 
wanting to burn the building down, 
so they cannot say you're too old.  
But, in my case, that's exactly what 
it was." [Participant 39] 
“During the time I was going 
through the process of getting on a 
heart transplant, they told me about 
the possibility of a bridge, you 
"But many people on LVADs when 
their opportunity comes up to get a 
replacement heart, or a transplant, I 
said, well, they turned it down because 
truthfully this thing's really not that 
big of a pain in the butt and I was 
somewhat shocked to find out that the 
average life span with a transplanted 
heart is ten years, ten years.  So, if you 
think about it, I would expect to live 
longer with this thing than ten years.  I 
mean, I think so." [Participant 39] 
“And, you know, I had hopes that this 
thing is not going to be just a 10-year 
deal for me.  Because, you know, 
because of the fact that they have told 
me that my heart is otherwise good.  I 
mean, basically, my electro 
cardiologist said, you know, he was in 




know, to transplant type situation.  
But then once I ended up going 
through the cancer situation, they 
told me I was going to be too old.  
And that it would end up being a 
destination deal for me.  I mean, 
they never say never.  But, you 
know, they said, you know, likely 
you’re going to be too old when-, 
you know, because you’re going to 
have to be free of cancer for three 
years basically.  And then you’re 
going to be too old.  You know?  
I’ll be 75 at that time.” [Participant 
37] 
"I think they're full of crap.  As far 
as the hearts go, because they're 
like, 'oh, you've got to have this 
under control, and this needs to be 
did.'  Why am I sitting here 
jumping through all these damn 
hoops, you know?  I quit smoking, 
started losing weight, started taking 
my calcium pills because of the 
osteoporosis, which was caused by 
the medicine they gave me, to 
begin with, so. . . I'm not trying to 
do it for battle.  A year and a half 
trying to get on the transplant list, 
I'm like . . . it don't make sense to 
try to go through all this." 
[Participant 1] 
"So, right now, I'm currently 
labeled as destination.  But, kind 
of, just my BMI is too much for, to 
be listed right away.  So, we did a 
gastric sleeve at the same time.  So, 
right now, I started at a weight of 
340.  Now I'm down to right 
around 275.  So, once I hit, I did 
220, 200-pound mark, we will start 
actively looking at more being on 
the list at that point." [Participant 
44] 
“It was my choice because, like I 
said, I'm not strong enough to be 
pristine.  And as a matter of fact, they 
had checked.  And they said the one 
area of the heart that had had the 
issues with the electrical impulses, he 
said, it’s still active.  And he thought 
there was a chance that my heart-, you 
know, I’d be among the few, relatively 
few that my heart would heal.  But, of 
course, I talked to Doctor XXX 
[Cardiologist], and he says, well, 
because of your age, we’re not going 
to turn it off [LVAD explant] or mess 
with it or whatever, you know, 





able to push everything away. And 
if you're not strong enough, you 
know, like I said, if you can't do it, 
then you're wasting someone else's 
heart.  And I just don't want to do 
that.  And I feel comfortable with 
my decision and—because, I mean, 
if I took that heart knowing that I 
wasn't strong enough to finish it, 
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Left Ventricular Assist Device Adjustment ImpacteD by Assigned Patient 




 Welcome by the PI and co-investigator 
 Present purpose of the study 
 Review reason for audio recording and note-taking 
 Discuss informed consent  
 Discuss confidentiality by researchers and participants 
 Discuss group interview and discussion etiquette (respect and consideration 
of others, one speaker at a time) 






Semi-Structured Interview Guide for Left Ventricular Assist Device Adjustment ImpacteD by 
Assigned Patient Trajectory (LVAD-ADAPT): A Qualitative Exploratory Study 
Principal Investigator Brittany Rhoades, APRN, PhD Candidate,  
The University of Texas Health Science Center at Houston Cizik School of 
Nursing 
 
Semi-Structured Guide Questions (Q) 
Q1  How did you first come to learn about a Left Ventricular Assist Device 
(LVAD)? 
Q2 Can you tell me how the LVAD impacted you physically?  Psychologically? 
Q3  Can you tell me about how the LVAD impacted your self-concept 
(positively and negatively)? 
Q4 Can you tell me about some of the roles that you have among your family 
and professionally?  How did the LVAD impact these roles? (e.g., spouse, 
family member, parent, financial provider, care taker, etc.) 
Q5 How did your family and friends respond to the LVAD? 
Q6 Can you tell me a little about the activities that require assistance from 
someone because of the LVAD?  
  Q7  Can you tell me how the LVAD impacted your activities of daily life? 
  Q8  What information would you give to best prepare someone for an LVAD? 





Interview Probing Questions Guide for Left Ventricular Assist Device Adjustment ImpacteD by 
Assigned Patient Trajectory (LVAD-ADAPT): A Qualitative Exploratory Study 
Principal Investigator Brittany Rhoades, APRN, PhD Candidate,  
The University of Texas Health Science Center at Houston Cizik School of 
Nursing 
 
Semi-Structured Guide Probes (P) 
P1 Recall the first time that you were informed you were going to need an 
LVAD? Describe how learning that you need an LVAD made you feel.   
 P2 What were you able to do that you could not do prior to the LVAD?  Were 
there activities that the LVAD hindered you from participating?   
 P3  What helped you adjust to living with the LVAD? 
 P4 Please describe your “role” within your family or your family dynamics.  
How did the LVAD impact your role within your family? Can you describe 
your occupation or professional role?  How did the LVAD impact this role? 
 P5  Tell me about the how your family responded when they first encountered 
your LVAD?  What was it like to participate in social activities with the 
LVAD? 
 P6  Overall, as time increases what activities have you become more 
independent because of the LVAD? 
P7  What activities do you find most challenging since LVAD implantation? 
What activities were better with the LVAD? 
P8 What information do you wish you would have known before implant 
regarding living with the LVAD?  How would knowing this information 
have impacted your adjustment to your LVAD? 
P9 What do you look forward to being able to do now that you have an 
LVAD? What activities are you disappointed that you cannot participate or 
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